Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention

The stented coronary artery remains at high-risk of complications, particularly in the form of stent thrombosis and in-stent restenosis. Improving our ability to identify patients at high-risk for these complications may provide opportunities for intervention. PAI-1 has been implicated in the pathop...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis research 2020-07, Vol.191, p.125-133
Hauptverfasser:	Jung, Richard G., Simard, Trevor, Di Santo, Pietro, Dhaliwal, Shan, Sypkes, Caleb, Duchez, Anne-Claire, Moreland, Robert, Taylor, Katlyn, Parlow, Simon, Visintini, Sarah, Labinaz, Alisha, Marbach, Jeffrey, Sarathy, Kiran, Bernick, Jordan, Joseph, Joanne, Boland, Paul, Abdel-Razek, Omar, Harnett, David T., Ramirez, F. Daniel, Hibbert, Benjamin
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Coronary artery disease Life Sciences Percutaneous coronary intervention Plasminogen activator inhibitor-1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!